Atypical parkinsonism in C9orf72 expansions: a case report and systematic review of 45 cases from the literature

Journal of Neurology

Volumn 263, Issue 3, 2016, Pages 558-574

  Wilke, Carlo ^a,b   Pomper, Jörn K ^a   Biskup, Saskia ^c   Puskás, Cornelia ^d   Berg, Daniela ^a,b   Synofzik, Matthis ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c CEGAT GMBH   (Germany)

^d Municipal Hospital Karlsruhe   (Germany)

Author keywords

C9orf72 repeat expansion; Electrooculography; Mesencephalic atrophy; Parkinsonism; Parkinson s disease; Progressive supranuclear palsy

Indexed keywords

FLUORINE 18; C9ORF72 PROTEIN, HUMAN; FLUORODEOXYGLUCOSE F 18; PROTEIN; REPETITIVE DNA;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; APRAXIA; ARTICLE; ATYPICAL PARKINSONISM; C9ORF72 GENE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ELECTROOCULOGRAPHY; FEMALE; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL NEUROIMAGING; GAIT DISORDER; GAZE PARALYSIS; GENE; GENE MUTATION; GENE STRUCTURE; GENETIC SCREENING; GENOTYPE; HUMAN; HYPOKINESIA; MIDDLE AGED; MONTREAL COGNITIVE ASSESSMENT; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOGRAPHY; PARKINSONISM; PERSONALITY DISORDER; PRIORITY JOURNAL; REPEAT EXPANSION; RIGIDITY; SPEECH DISORDER; SYSTEMATIC REVIEW; TREMOR; VESTIBULOOCULAR REFLEX; AGED; BRAIN; DIAGNOSTIC IMAGING; FAMILY HEALTH; GENETICS; MALE; MEDLINE; POSITRON EMISSION TOMOGRAPHY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; DNA REPEAT EXPANSION; ELECTROOCULOGRAPHY; FAMILY HEALTH; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PROTEINS; PUBMED; YOUNG ADULT;

EID: 84960378654     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-016-8021-7     Document Type: Article

References (57)

1. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245–256. doi:10.1016/j.neuron.2011.09.011
2. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding JH, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ, Consortium I (2011) A hexanucleotide repeat expansion in C9ORF72 Is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257–268. doi:10.1016/j.neuron.2011.09.010
3. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR Jr, Parisi JE, Lucas JA, Petersen RC, Rademakers R (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135(Pt 3):765–783. doi:10.1093/brain/aws004
4. Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, Martindale J, Hartley J, Walsh T, Gelsthorpe C, Baxter L, Forster G, Fox M, Bury J, Mok K, McDermott CJ, Traynor BJ, Kirby J, Wharton SB, Ince PG, Hardy J, Shaw PJ (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135(Pt 3):751–764. doi:10.1093/brain/awr365
5. Devenney E, Hornberger M, Irish M, Mioshi E, Burrell J, Tan R, Kiernan MC, Hodges JR (2014) Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol 71(3):331–339. doi:10.1001/jamaneurol.2013.6002
6. Rohrer JD, Isaacs AM, Mizielinska S, Mead S, Lashley T, Wray S, Sidle K, Fratta P, Orrell RW, Hardy J, Holton J, Revesz T, Rossor MN, Warren JD (2015) C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol 14(3):291–301. doi:10.1016/S1474-4422(14)70233-9
7. Goldman JS, Quinzii C, Dunning-Broadbent J, Waters C, Mitsumoto H, Brannagan TH 3rd, Cosentino S, Huey ED, Nagy P, Kuo SH (2014) Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72. JAMA Neurol 71(6):771–774. doi:10.1001/jamaneurol.2013.5762
8. Lindquist SG, Duno M, Batbayli M, Puschmann A, Braendgaard H, Mardosiene S, Svenstrup K, Pinborg LH, Vestergaard K, Hjermind LE, Stokholm J, Andersen BB, Johannsen P, Nielsen JE (2013) Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin Genet 83(3):279–283. doi:10.1111/j.1399-0004.2012.01903.x
9. O’Dowd S, Curtin D, Waite AJ, Roberts K, Pender N, Reid V, O’Connell M, Williams NM, Morris HR, Traynor BJ, Lynch T (2012) C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism. Mov Disord 27(8):1072–1074. doi:10.1002/mds.25022
10. Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, Adamson G, Mudanohwo E, McColgan P, Haworth A, Wild EJ, Sweeney MG, Houlden H, Mead S, Tabrizi SJ (2014) C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 82(4):292–299. doi:10.1212/wnl.0000000000000061
11. Lesage S, Le Ber I, Condroyer C, Broussolle E, Gabelle A, Thobois S, Pasquier F, Mondon K, Dion PA, Rochefort D, Rouleau GA, Durr A, Brice A, French Parkinson’s Disease Genetics Study G (2013) C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain 136(Pt 2):385–391. doi:10.1093/brain/aws357
12. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1–9
13. Kennard C (2011) Disorders of higher gaze control. Handbook of clinical neurology 102:379–402. doi:10.1016/B978-0-444-52903-9.00020-0
14. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
15. Pinkhardt EH, Jurgens R, Becker W, Valdarno F, Ludolph AC, Kassubek J (2008) Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson’s syndrome, and idiopathic Parkinson’s disease. J Neurol 255(12):1916–1925. doi:10.1007/s00415-009-0027-y
16. Rottach KG, Riley DE, DiScenna AO, Zivotofsky AZ, Leigh RJ (1996) Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol 39(3):368–377. doi:10.1002/ana.410390314
17. Troost BT, Daroff RB (1977) The ocular motor defects in progressive supranuclear palsy. Ann Neurol 2(5):397–403. doi:10.1002/ana.410020509
18. Rascol O, Sabatini U, Fabre N, Senard JM, Simonetta-Moreau M, Montastruc JL, Clanet M, Rascol A (1995) Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson’s disease. Mov Disord 10(2):163–170. doi:10.1002/mds.870100206
19. Dix MR, Harrison MJ, Lewis PD (1971) Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome). A report of nine cases with particular reference to the mechanism of the oculomotor disorder. J Neurol Sci 13(3):237–256
20. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 128(Pt 6):1247–1258. doi:10.1093/brain/awh488
21. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L (2001) Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 58(7):1076–1079
22. Boeve BF, Graff-Radford NR (2012) Cognitive and behavioral features of c9FTD/ALS. Alzheimers Res Ther 4(4):29. doi:10.1186/alzrt132
23. Floris G, Borghero G, Cannas A, Di Stefano F, Costantino E, Murru MR, Brunetti M, Restagno G, Traynor BJ, Marrosu MG, Chio A, Marrosu F (2012) Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype? J Neurol 259(8):1749–1751. doi:10.1007/s00415-012-6444-3
24. Savica R, Adeli A, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Whitwell J, Jack CR, Lowe V, Petersen RC, Boeve BF (2012) Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72. Arch Neurol 69(9):1164–1169. doi:10.1001/archneurol.2012.772
25. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, Jones M, Gerhard A, Davidson YS, Robinson A, Gibbons L, Hu Q, DuPlessis D, Neary D, Mann DM, Pickering-Brown SM (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135(Pt 3):693–708. doi:10.1093/brain/awr355
26. Takada LT, Pimentel ML, Dejesus-Hernandez M, Fong JC, Yokoyama JS, Karydas A, Thibodeau MP, Rutherford NJ, Baker MC, Lomen-Hoerth C, Rademakers R, Miller BL (2012) Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation. Arch Neurol 69(9):1149–1153. doi:10.1001/archneurol.2012.650
27. Snowden JS, Rollinson S, Lafon C, Harris J, Thompson J, Richardson AM, Jones M, Gerhard A, Neary D, Mann DM, Pickering-Brown S (2012) Psychosis, C9ORF72 and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 83(10):1031–1032. doi:10.1136/jnnp-2012-303032
28. Xi Z, Zinman L, Grinberg Y, Moreno D, Sato C, Bilbao JM, Ghani M, Hernandez I, Ruiz A, Boada M, Moron FJ, Lang AE, Marras C, Bruni A, Colao R, Maletta RG, Puccio G, Rainero I, Pinessi L, Galimberti D, Morrison KE, Moorby C, Stockton JD, Masellis M, Black SE, Hazrati LN, Liang Y, van Haersma de With J, Fornazzari L, Villagra R, Rojas-Garcia R, Clarimon J, Mayeux R, Robertson J, St George-Hyslop P, Rogaeva E (2012) Investigation of c9orf72 in 4 neurodegenerative disorders. Arch Neurol 69(12):1583–1590. doi:10.1001/archneurol.2012.2016
29. Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, Butler R, Leung B, Fok A, Rutherford NJ, Baker M, Rademakers R, Mackenzie IR (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain 135(Pt 3):709–722. doi:10.1093/brain/awr354
30. Annan M, Beaufils E, Viola UC, Vourc’h P, Hommet C, Mondon K (2013) Idiopathic Parkinson’s disease phenotype related to C9ORF72 repeat expansions: contribution of the neuropsychological assessment. BMC Res Notes 6:343. doi:10.1186/1756-0500-6-343
31. Cooper-Knock J, Frolov A, Highley JR, Charlesworth G, Kirby J, Milano A, Hartley J, Ince PG, McDermott CJ, Lashley T, Revesz T, Shaw PJ, Wood NW, Bandmann O (2013) C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study. Neurology 81(9):808–811. doi:10.1212/WNL.0b013e3182a2cc38
32. Le Ber I, Camuzat A, Guillot-Noel L, Hannequin D, Lacomblez L, Golfier V, Puel M, Martinaud O, Deramecourt V, Rivaud-Pechoux S, Millecamps S, Vercelletto M, Couratier P, Sellal F, Pasquier F, Salachas F, Thomas-Anterion C, Didic M, Pariente J, Seilhean D, Ruberg M, Wargon I, Blanc F, Camu W, Michel BF, Berger E, Sauvee M, Thauvin-Robinet C, Mondon K, Tournier-Lasserve E, Goizet C, Fleury M, Viennet G, Verpillat P, Meininger V, Duyckaerts C, Dubois B, Brice A (2013) C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimer’s Dis JAD 34(2):485–499. doi:10.3233/jad-121456
33. Mann DM, Rollinson S, Robinson A, Bennion Callister J, Thompson JC, Snowden JS, Gendron T, Petrucelli L, Masuda-Suzukake M, Hasegawa M, Davidson Y, Pickering-Brown S (2013) Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun 1(1):68. doi:10.1186/2051-5960-1-68
34. Origone P, Verdiani S, Ciotti P, Gulli R, Bellone E, Marchese R, Abbruzzese G, Mandich P (2013) Enlarging the clinical spectrum associated with C9orf 72 repeat expansions: findings in an Italian cohort of patients with parkinsonian syndromes and relevance for genetic counselling. Amyotrop Lat Scler front Degen 14(5–6):479–480. doi:10.3109/21678421.2013.774020
35. Landqvist Waldo M, Gustafson L, Nilsson K, Traynor BJ, Renton AE, Englund E, Passant U (2013) Frontotemporal dementia with a C9ORF72 expansion in a Swedish family: clinical and neuropathological characteristics. Am J Neurodegen Dis 2(4):276–286
36. Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Kruger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschlander A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Van Broeckhoven C (2014) Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. Neurology 83(21):1906–1913. doi:10.1212/wnl.0000000000001012
37. Danaila T, Polo G, Klinger H, Broussolle E, Mertens P, Lesage S, Brice A, Thobois S (2014) Efficacy of subthalamic nucleus stimulation in C9ORF72 expansion related parkinsonism. Parkinsonism Relat Disord 20(10):1104–1105. doi:10.1016/j.parkreldis.2014.07.010
38. Ticozzi N, Tiloca C, Calini D, Gagliardi S, Altieri A, Colombrita C, Cereda C, Ratti A, Pezzoli G, Borroni B, Goldwurm S, Padovani A, Silani V (2014) C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. Neurobiol Aging 35(4):936 e913–936 e937. doi:10.1016/j.neurobiolaging.2013.09.037
39. Koutsis G, Karadima G, Kartanou C, Kladi A, Panas M (2015) C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population. Neurobiol Aging 36(1):547 e513–547 e546. doi:10.1016/j.neurobiolaging.2014.08.020
40. Schottlaender LV, Polke JM, Ling H, MacDoanld ND, Tucci A, Nanji T, Pittman A, de Silva R, Holton JL, Revesz T, Sweeney MG, Singleton AB, Lees AJ, Bhatia KP, Houlden H (2015) The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism. Neurobiol Aging 36(2):1221 e1221–1221 e1226. doi:10.1016/j.neurobiolaging.2014.08.024
41. Shinagawa S, Naasan G, Karydas AM, Coppola G, Pribadi M, Seeley WW, Trojanowski JQ, Miller BL, Grinberg LT (2015) Clinicopathological study of patients with C9ORF72-associated frontotemporal dementia presenting with delusions. J Geriatr Psychiatry Neurol 28(2):99–107. doi:10.1177/0891988714554710
42. Anor CJ, Xi Z, Zhang M, Moreno D, Sato C, Rogaeva E, Tartaglia MC (2015) Mutation analysis of C9orf72 in patients with corticobasal syndrome. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2015.06.008
43. Luigetti M, Quaranta D, Conte A, Piccininni C, Lattante S, Romano A, Silvestri G, Zollino M, Sabatelli M (2013) Frontotemporal dementia, Parkinsonism and lower motor neuron involvement in a patient with C9ORF72 expansion. Amyotrop Later Scler Front Degen 14(1):66–69. doi:10.3109/17482968.2012.692383
44. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184
45. Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW (2011) Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 122(6):673–690. doi:10.1007/s00401-011-0907-y
46. Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, De Vita E, Masellis M, Black SE, Freedman M, Keren R, MacIntosh BJ, Rogaeva E, Tang-Wai D, Tartaglia MC, Laforce R Jr, Tagliavini F, Tiraboschi P, Redaelli V, Prioni S, Grisoli M, Borroni B, Padovani A, Galimberti D, Scarpini E, Arighi A, Fumagalli G, Rowe JB, Coyle-Gilchrist I, Graff C, Fallstrom M, Jelic V, Stahlbom AK, Andersson C, Thonberg H, Lilius L, Frisoni GB, Pievani M, Bocchetta M, Benussi L, Ghidoni R, Finger E, Sorbi S, Nacmias B, Lombardi G, Polito C, Warren JD, Ourselin S, Fox NC, Rossor MN (2015) Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. doi:10.1016/S1474-4422(14)70324-2
47. Cooper-Knock J, Kirby J, Highley R, Shaw PJ (2015) The spectrum of C9orf72-mediated neurodegeneration and amyotrophic lateral sclerosis. Neurotherapeutics 12(2):326–339. doi:10.1007/s13311-015-0342-1
48. Koppers M, Blokhuis AM, Westeneng HJ, Terpstra ML, Zundel CA, Vieira de Sa R, Schellevis RD, Waite AJ, Blake DJ, Veldink JH, van den Berg LH, Pasterkamp RJ (2015) C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann Neurol. doi:10.1002/ana.24453
49. Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee K-H, Badders N, Valentine M, Miller BL, Wong PC, Petrucelli L, Kim HJ, Gao F-B, Taylor JP (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nat Adv Online Publ. doi:10.1038/nature14974
50. Chew J, Gendron TF, Prudencio M, Sasaguri H, Zhang YJ, Castanedes-Casey M, Lee CW, Jansen-West K, Kurti A, Murray ME, Bieniek KF, Bauer PO, Whitelaw EC, Rousseau L, Stankowski JN, Stetler C, Daughrity LM, Perkerson EA, Desaro P, Johnston A, Overstreet K, Edbauer D, Rademakers R, Boylan KB, Dickson DW, Fryer JD, Petrucelli L (2015) Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348(6239):1151–1154. doi:10.1126/science.aaa9344
51. Kostic VS, Dobricic V, Stankovic I, Ralic V, Stefanova E (2014) C9orf72 expansion as a possible genetic cause of Huntington disease phenocopy syndrome. J Neurol 261(10):1917–1921. doi:10.1007/s00415-014-7430-8
52. Luzzi S, Girelli F, Fiori C, Ranaldi V, Baldinelli S, Cameriere V, Silvestrini M, Provinciali L, Rollinson S, Pickering-Brown S, Mann D, Snowden JS (2015) Left hand dystonia as a recurring feature of a family carrying C9ORF72 mutation. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2015-311311
53. Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9(12):1200–1213. doi:10.1016/S1474-4422(10)70212-X
54. Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65(8):1239–1245. doi:10.1212/01.wnl.0000180516.69442.95
55. Bak TH, Rogers TT, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR (2005) Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 76(3):420–422. doi:10.1136/jnnp.2003.029595
56. Rittman T, Ghosh BC, McColgan P, Breen DP, Evans J, Williams-Gray CH, Barker RA, Rowe JB (2013) The Addenbrooke’s Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry 84(5):544–551. doi:10.1136/jnnp-2012-303618
57. Synofzik M, Biskup S, Leyhe T, Reimold M, Fallgatter AJ, Metzger F (2012) Suicide attempt as the presenting symptom of C9orf72 dementia. AJ Psychiatry 169(11):1211–1213. doi:10.1176/appi.ajp.2012.12060733